Staging Coronary Risk: A New TRANSFORMative Approach
Staging Coronary Risk: A New TRANSFORMative Approach
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD
Current Unmet Needs in the Field of Unresectable HCC
Current Unmet Needs in the Field of Unresectable HCC
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
You Don’t Know WHIM Syndrome (A Chronic Neutropenic Disorder)
Evolving Our View of the Coagulation Cascade and Stroke Management
Evolving Our View of the Coagulation Cascade and Stroke Management
Predicting Response to Neoadjuvant and Perioperative Chemoimmunotherapy
Predicting Response to Neoadjuvant and Perioperative Chemoimmunotherapy
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
WHIM Syndrome and CXCR4 Variants: New Insights into Cellular Changes That Can Impact Patient Treatment Plans
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC